Nuzenio

Cogent Biosciences Reports

Cogent Biosciences Reports news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 11 latest news signals 4 publisher sources 100/100 entity strength

Latest news

Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2026 Financial Results - Investing News NetworkInvesting News Network · Mon, 10 Aug 2026 23:23:26 GMTCogent Biosciences (COGT) files prospectus for $400M at-the-market stock program - Stock TitanStock Titan · Mon, 10 Aug 2026 21:20:09 GMTCogent Biosciences (NASDAQ: COGT) details cash runway and bezuclastinib FDA timelines - Stock TitanStock Titan · Mon, 10 Aug 2026 20:12:14 GMTCogent Biosciences set to report earnings ahead of FDA decisions - Investing.comInvesting.com · Mon, 10 Aug 2026 14:09:00 GMTCogent Biosciences (NASDAQ:COGT) Announces Earnings Results - MarketBeatMarketBeat · Mon, 10 Aug 2026 12:41:49 GMTCogent Biosciences (COGT) widens Q2 loss but nears FDA decisions on bezuclastinib - Stock TitanStock Titan · Mon, 10 Aug 2026 12:06:57 GMTCogent’s Bezuclastinib Could Reach FDA Decisions in Nov., Dec. - Stock TitanStock Titan · Mon, 10 Aug 2026 12:00:00 GMTVanguard Capital Management discloses 5.08% Cogent Biosciences (COGT) ownership in 13G filing - Stock TitanStock Titan · Fri, 31 Jul 2026 07:00:00 GMT

Timeline

Mon, 10 Aug 2026 23:23:26 GMTCogent Biosciences Reports Recent Business Highlights and Second Quarter 2026 Financial Results - Investing News Network
Mon, 10 Aug 2026 21:20:09 GMTCogent Biosciences (COGT) files prospectus for $400M at-the-market stock program - Stock Titan
Mon, 10 Aug 2026 20:12:14 GMTCogent Biosciences (NASDAQ: COGT) details cash runway and bezuclastinib FDA timelines - Stock Titan
Mon, 10 Aug 2026 14:09:00 GMTCogent Biosciences set to report earnings ahead of FDA decisions - Investing.com
Mon, 10 Aug 2026 12:41:49 GMTCogent Biosciences (NASDAQ:COGT) Announces Earnings Results - MarketBeat
Mon, 10 Aug 2026 12:06:57 GMTCogent Biosciences (COGT) widens Q2 loss but nears FDA decisions on bezuclastinib - Stock Titan

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Cogent Biosciences Reports.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

4 distinct publisher/source names are currently connected to this entity page.